Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years) Who Have Stage 1 or 2 Essential Hypertension
1 other identifier
interventional
641
1 country
75
Brief Summary
The purpose of this study is to assess the efficacy, safety, and tolerability of 8 weeks of therapy with nebivolol in comparison to placebo in younger patients 18 - 54 years of age with stage 1 or stage 2 essential hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4 hypertension
Started Aug 2011
Shorter than P25 for phase_4 hypertension
75 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 10, 2011
CompletedFirst Posted
Study publicly available on registry
August 12, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedResults Posted
Study results publicly available
May 16, 2013
CompletedMay 16, 2013
March 1, 2013
7 months
August 10, 2011
March 18, 2013
March 18, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Trough Seated Diastolic Blood Pressure (DBP)
Change from baseline in mean seated trough cuff Diastolic Blood Pressure (DBP) at Week 8 as measured by an Omron device. The primary efficacy analysis was based on the Intent to Treat (ITT) population using a Last Observation Carried Forward (LOCF) approach.
Change from Baseline to Week 8
Secondary Outcomes (1)
Trough Seated Systolic Blood Pressure (SBP)
Change from Baseline to Week 8
Study Arms (2)
1
EXPERIMENTALNebivolol (non-trade 5, 10 or 20 mg tablet), oral administration
2
PLACEBO COMPARATORDose-matched placebo
Interventions
Eligibility Criteria
You may qualify if:
- Male and female outpatients, of age 18 - 54 years
- Patients diagnosed with stage 1 or stage 2 essential hypertension
- Normal physical examination findings and electrocardiogram (ECG) results or abnormal findings judged by the Investigator to be not clinically significant
You may not qualify if:
- Secondary hypertension or severe hypertension
- History of Type 1 diabetes mellitus
- A medical contraindication to discontinuing a current antihypertensive therapy
- Clinically significant respiratory disease that prohibit use of a beta blocker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (75)
Forest Investigative Site 065
Phoenix, Arizona, 85014, United States
Forest Investigative Site 067
Phoenix, Arizona, 85014, United States
Forest Investigative Site 070
Phoenix, Arizona, 85014, United States
Forest Investigative Site 049
Buena Park, California, 90620, United States
Forest Investigative Site 034
Burbank, California, 91505, United States
Forest Investigative Site 039
Costa Mesa, California, 92626, United States
Forest Investigative Site 024
Fountain Valley, California, 92708, United States
Forest Investigative Site 020
Fresno, California, 93726, United States
Forest Investigative Site 021
Fresno, California, 93726, United States
Forest Investigative Site 040
Greenbrae, California, 94904, United States
Forest Investigative Site 047
La Mesa, California, 91942, United States
Forest Investigative Site 073
Los Angeles, California, 90057, United States
Forest Investigative Site 077
Roseville, California, 95661, United States
Forest Investigative Site 060
San Bernardino, California, 92404, United States
Forest Investigative Site 054
San Francisco, California, 94115, United States
Forest Investigative Site 018
Spring Valley, California, 91978, United States
Forest Investigative Site 028
Denver, Colorado, 80220, United States
Forest Investigative Site 059
Brooksville, Florida, 34601, United States
Forest Investigative Site 033
Fort Lauderdale, Florida, 33306, United States
Forest Investigative Site 006
Hallandale, Florida, 33009, United States
Forest Investigative Site 044
Longwood, Florida, 32779, United States
Forest Investigative Site 001
Miami, Florida, 33014, United States
Forest Investigative Site 012
Miami, Florida, 33014, United States
Forest Investigative Site 032
Miami, Florida, 33014, United States
Forest Investigative Site 055
Miami, Florida, 33014, United States
Forest Investigative Site 045
Oviedo, Florida, 32765, United States
Forest Investigative Site 031
St. Petersburg, Florida, 33709, United States
Forest Investigative Site 009
Atlanta, Georgia, 30084, United States
Forest Investigative Site 007
Chicago, Illinois, 60611, United States
Forest Investigative Site 004
Morton, Illinois, 61550, United States
Forest Investigative Site 072
Evansville, Indiana, 47713, United States
Forest Investigative Site 069
Newburgh, Indiana, 47630, United States
Forest Investigative Site 025
Augusta, Kansas, 67010, United States
Forest Investigative Site 029
Louisville, Kentucky, 40213, United States
Forest Investigative Site 068
Madisonville, Kentucky, 42431, United States
Forest Investigative Site 061
Metairie, Louisiana, 70005, United States
Forest Investigative Site 057
New Orleans, Louisiana, 70119, United States
Forest Investigative Site 058
New Orleans, Louisiana, 70119, United States
Forest Investigative Site 008
Lutherville, Maryland, 21093, United States
Forest Investigative Site 062
Fall River, Massachusetts, 02702, United States
Forest Investigative Site 075
Paw Paw, Michigan, 49079, United States
Forest Investigative Site 019
Brooklyn Center, Minnesota, 55430, United States
Forest Investigative Site 017
Chaska, Minnesota, 55318, United States
Forest Investigative Site 038
Belzoni, Mississippi, 39038, United States
Forest Investigative Site 035
Olive Branch, Mississippi, 38654, United States
Forest Investigative Site 023
Las Vegas, Nevada, 89101, United States
Forest Investigative Site 048
Las Vegas, Nevada, 89101, United States
Forest Investigative Site 052
Las Vegas, Nevada, 89101, United States
Forest Investigative Site 014
Elizabeth, New Jersey, 27609, United States
Forest Investigative Site 051
Trenton, New Jersey, 08611, United States
Forest Investigative Site 003
Asheboro, North Carolina, 27203, United States
Forest Investigative Site 010
Charlotte, North Carolina, 28277, United States
Forest Investigative Site 011
Raleigh, North Carolina, 27609, United States
Forest Investigative Site 016
Raleigh, North Carolina, 27609, United States
Forest Investigative Site 005
Wilmington, North Carolina, 28401, United States
Forest Investigative Site 036
Winston-Salem, North Carolina, 27103, United States
Forest Investigative Site 002
Columbus, Ohio, 43213, United States
Forest Investigative Site 050
Norman, Oklahoma, 73069, United States
Forest Investigative Site 030
Portland, Oregon, 33709, United States
Forest Investigative Site 056
Downingtown, Pennsylvania, 19335, United States
Forest Investigative Site 022
Pelzer, South Carolina, 29669, United States
Forest Investigative Site 053
Beaumont, Texas, 77701, United States
Forest Investigative Site 066
Boerne, Texas, 78006, United States
Forest Investigative Site 076
Corpus Christi, Texas, 78404, United States
Forest Investigative Site 037
Dallas, Texas, 75234, United States
Forest Investigative Site 043
Haltom City, Texas, 84070, United States
Forest Investigative Site 015
Houston, Texas, 77081, United States
Forest Investigative Site 026
Houston, Texas, 77081, United States
Forest Investigative Site 027
Houston, Texas, 77081, United States
Forest Investigative Site 074
Houston, Texas, 77081, United States
Forest Investigative Site 071
Orem, Utah, 84058, United States
Forest Investigative Site 042
Sandy City, Utah, 84070, United States
Forest Investigative Site 063
Norfolk, Virginia, 23502, United States
Forest Investigative Site 064
Norfolk, Virginia, 23502, United States
Forest Investigative Site 046
Port Orchard, Washington, 98366, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Tatjana Lukic, MD, MSc
- Organization
- Forest Research Institute
Study Officials
- STUDY DIRECTOR
Tatjana Lukic, MD, M. Sc.
Forest Laboratories
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2011
First Posted
August 12, 2011
Study Start
August 1, 2011
Primary Completion
March 1, 2012
Study Completion
April 1, 2012
Last Updated
May 16, 2013
Results First Posted
May 16, 2013
Record last verified: 2013-03